Agonist-specific regulation of δ-opioid receptor trafficking by G protein-coupled receptor kinase and β-arrestin

被引:49
作者
Zhang, J
Ferguson, SSG
Law, PY
Barak, LS
Caron, MG [1 ]
机构
[1] Duke Univ, Med Ctr, Howard Hughes Med Inst Labs, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA
[3] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA
来源
JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH | 1999年 / 19卷 / 1-4期
关键词
D O I
10.3109/10799899909036653
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Opioid receptors mediate multiple biological functions through their interaction with endogenous opioid peptides as well as opioid alkaloids including morphine and etorphine. Previously we have reported that the ability of distinct opioid agonists to differentially regulate CL-opioid receptor (mu OR) responsiveness is related to their ability to promote G protein-coupled receptor kinase (GRK)-dependent phosphorylation of the receptor (1). In the present study, we further examined the role of GRK and p-arrestin in agonist-specific regulation of the delta-opioid receptor (delta OR). While both etorphine and morphine effectively activate the SBR, only etorphine triggers robust delta OR phosphorylation followed by plasma membrane translocation of beta-arrestin and receptor internalization. In contrast, morphine is unable to either elicit FOR phosphorylation or stimulate beta-arrestin translocation, correlating with its inability to cause FOR internalization. Unlike for the mu OR, overexpression of GRK2 results in neither the enhancement of delta OR sequestration nor the rescue of FOR-mediated p-arrestin translocation. Therefore, our findings not only point to the existence of marked differences in the ability of different opioid agonists to promote delta OR phosphorylation by GRK and binding to beta-arrestin, but also demonstrate differences in the regulation of two opioid receptor subtypes. These observations may have important implications for our understanding of the distinct ability of various opioids in inducing opioid tolerance and addiction.
引用
收藏
页码:301 / 313
页数:13
相关论文
共 27 条
[1]   Molecular mechanism of desensitization of the chemokine receptor CCR-5: receptor signaling and internalization are dissociable from its role as an HIV-1 co-receptor [J].
Aramori, I ;
Zhang, J ;
Ferguson, SSG ;
Bieniasz, PD ;
Cullen, BR ;
Caron, MG .
EMBO JOURNAL, 1997, 16 (15) :4606-4616
[2]   A beta-arrestin green fluorescent protein biosensor for detecting G protein-coupled receptor activation [J].
Barak, LS ;
Ferguson, SSG ;
Zhang, J ;
Caron, MG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (44) :27497-27500
[3]   delta and kappa opioid receptors are differentially regulated by dynamin-dependent endocytosis when activated by the same alkaloid agonist [J].
Chu, P ;
Murray, S ;
Lissin, D ;
vonZastrow, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (43) :27124-27130
[4]  
CULLEN BR, 1987, METHOD ENZYMOL, V152, P684
[5]   Dimerization of the delta opioid receptor: Implication for a role in receptor internalization [J].
Cvejic, S ;
Devi, LA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (43) :26959-26964
[6]   CLONING OF A DELTA OPIOID RECEPTOR BY FUNCTIONAL EXPRESSION [J].
EVANS, CJ ;
KEITH, DE ;
MORRISON, H ;
MAGENDZO, K ;
EDWARDS, RH .
SCIENCE, 1992, 258 (5090) :1952-1955
[7]   ROLE OF PHOSPHORYLATION IN AGONIST-PROMOTED BETA(2)-ADRENERGIC RECEPTOR SEQUESTRATION - RESCUE OF A SEQUESTRATION-DEFECTIVE MUTANT RECEPTOR BY BETA-ARK1 [J].
FERGUSON, SSG ;
MENARD, L ;
BARAK, LS ;
KOCH, WJ ;
COLAPIETRO, AM ;
CARON, MG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (42) :24782-24789
[8]   Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization [J].
Ferguson, SSG ;
Downey, WE ;
Colapietro, AM ;
Barak, LS ;
Menard, L ;
Caron, MG .
SCIENCE, 1996, 271 (5247) :363-366
[9]   beta-arrestin acts as a clathrin adaptor in endocytosis of the beta(2)-adrenergic receptor [J].
Goodman, OB ;
Krupnick, JG ;
Santini, F ;
Gurevich, VV ;
Penn, RB ;
Gagnon, AW ;
Keen, JH ;
Benovic, JL .
NATURE, 1996, 383 (6599) :447-450
[10]  
Itokawa M, 1996, MOL PHARMACOL, V49, P560